The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis

Current Eye Research

Volumn 31, Issue 3, 2006, Pages 225-230

  McCormick, Clare C ^a   Dajcs, Joseph J ^a   Reed, Julian M ^a   Marquart, Mary E ^a   O'Callaghan, Richard J ^b,c  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LSU EYE CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Coagulase negative; Endophthalmitis; Lysostaphin; Staphylococcus

Indexed keywords

LYSOSTAPHIN; METICILLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; ENDOPHTHALMITIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS COHNII; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS SIMULANS; STAPHYLOCOCCUS WARNERI; TREATMENT OUTCOME; VITREOUS BODY;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; DISEASE MODELS, ANIMAL; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; INJECTIONS; LYSOSTAPHIN; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TREATMENT OUTCOME; VITREOUS BODY;

EID: 33644911229     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680500536753     Document Type: Article

References (40)

1. Lowy FD, Hammer SM. Staphylococcus epidermidis infections. Ann Intern Med 1983;99:834-839.
2. Benz MS, Scott IU, Flynn HW Jr, et al. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol. 2004;137:38-42.
3. Huebner J, Goldmann DA. Coagulase-negative staphylococci: role as pathogens. Annu Rev Med. 1999;50:223-236.
4. Perkins RE, Kundsin RB, Pratt MV, et al. Bacteriology of normal and infected conjunctiva. J Clin Microbiol. 1975;1:147-149.
5. Speaker MG, Milch FA, Shah MK, et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991;98(5):639-649.
6. Izquierdo N, Diaz Mendoza S, Townsend W, et al. Prevalence of the microbiologic flora in contact lens wearers at the Puerto Rico Medical Center. J Bol Assoc Med P R. 1991;83(3)96-98.
7. Willcox MDP, Stapleton F. Ocular bacteriology. Rev Med Micro. 1996;7:123-131.
8. Leitch EC, Harmis NY, Corrigan KM, Willcox MD. Identification and enumeration of staphylococci from the eye during soft contact lens wear. Optom Vis Sci. 1998;7B: 258-265.
9. Sotozono C, Inagaki K, Fujita A, et al. Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea. Cornea. 2002;21:S94-101.
10. Hyndiuk RA, Eiferman RA, Caldwell DR, et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology. 1996;103:1854-1862.
11. Tabbara KF, El-Sheikh HF, Islam SM, Hammouda E. Treatment of acute bacterial conjunctivitis with topical lomefloxacin 0.3% compared to topical ofloxacin 0.3%. Eur J Ophthalmol. 1999;9:269-275.
12. Tavakkoli H, Sugar J. Microbial keratitis following penetrating keratoplasty. Ophthalmic Surg. 1994;25:356-360.
13. Bannerman TL, Rhoden DL, McAllister SK, et al. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol. 1997;115:357-361.
14. Wong T, Ormonde S, Gamble G, McGhee CN. Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol. 2003;87:1103-1108.
15. Bode DD Jr, Gelender H, Forster RK. A retrospective review of endophthalmitis due to coagulase-negative staphylococci. Br J Ophthalmol. 1985;69:915-919.
16. Driebe WT Jr, Mandelbaum S, Forster RK, et al. Pseudophakic endophthalmitis. Diagnosis and management. Ophthalmology. 1986;93:442-448.
17. Heaven CJ, Mann PJ, Boase DL. Endophthalmitis following extra-capsular cataract surgery: a review of 32 cases. Br J Ophthalmol. 1992;76:419-423.
18. Shrader SK, Band JD, Lauter CB, Murphy P. The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis. 1990;162:115-120.
19. Aaberg TM Jr, Flynn HW Jr, Schiffman J, et al. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. J Ophthalmol. 1998;105:1004-1010.
20. Callegan MC, Engelbert M, Parke DW 2nd, et al. Bacterial endophthalmitis: Epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15:111-124.
21. Beigi B, Westlake W, Mangelschots E, et al. Peroperative microbial contamination of anterior chamber aspirates during extracapsular cataract extraction and phacoemulsification. Br J Ophthalmol. 1997;81:953-955.
22. Kattan HM, Flynn HW Jr, Pflugfelder SC, et al. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology. 1991;98:227-238.
23. Kato T, Hayasaka S. Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci from conjunctivas of preoperative patients. Jpn J Ophthalmol. 1998;42:461-465.
24. Peyman GA, Sathar ML, May DR. Intraocular gentamicin as intraoperative prophylaxis in South India eye camps. Br J Ophthalmol. 1977;61:260-262.
25. Baum J, Peyman GA, Barza M. Intravitreal administration of antibiotic in the treatment of bacterial endophthalmitis. III. Consensus. Survey. Ophthalmology. 1982;26:204-206.
26. Fisher JP, Civiletto SE, Forster RK. Toxicity, efficacy, and clearance of intravitreally injected of cefazolin. Arch Ophthalmol. 1982;100:650-652.
27. Hopen G, Mondino BJ, Kozy D, Lipkowitz J. Intraocular lenses and experimental bacterial endophthalmitis. Am J Ophthalmol. 1982;94:402-407.
28. Rutgard JJ, Berkowitz RA, Peyman GA. Intravitreal cephalothin in experimental staphylococcal endophthalmitis. Ann Ophthalmol. 1978;10:293-298.
29. Smith MA, Sorenson JA, Lowy FD, et al. Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin. Ophthalmology. 1986;93:1328-1335.
30. Gan IM, van Dissel JT, Beekhuis WH, et al. Intravitreal vancomycin and gentamicin concentrations in patients with postoperative endophthalmitis. Br J Ophthalmol. 2001;85:1289-1293.
31. Ferro JF, de-Pablos M, Logrono MJ, et al. Postoperative contamination after using vancomycin and gentamicin during phacoemulsification. Arch Ophthalmol. 1997;115:165-170.
32. Fleischer AB, Hoover DL, Khan JA, et al. Topical vancomycin formulation for methicillin-resistant Staphylococcus epidermidis blepharoconjuctivitis. Am J Ophthalmol. 1986:101,283-287
33. Goodman DF, Gottsch JD. Methicillin-resistant Staphylococcus epidermidis keratitis treated with vancomycin. Arch Ophthalmol. 1988;106:1570-1571.
34. Maffett M, O'Day DM. Ciprofloxacin-resistant bacterial keratitis. Am J Ophthalmol. 1993;115,545-546.
35. Axer-Siegel R, Stiebel-Kalish H, Rosenblatt I, et al. Cystoid macular edema after cataract surgery with intraocular vancomycin. Ophthalmology. 1999;106:1660-1664.
36. W. JA, Kusuma C, Mond JJ, Kokai-Kun JF. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother. 2003 47(11):3407-3414.
37. Schindler CA, Schuhart VT. Lysostaphin: A new bacteriolytic agent for the Staphylococcus. Proc Natl Acad Sci USA 1965;51:414-421.
38. Dajcs JJ, Hume EB, Moreau JM, et al. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Invest Ophthalmol Vis Sci. 2000;41:1432-1437.
39. Dajcs JJ, Thibodeaux BA, Hume EB, et al. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit. Curr Eye Res. 2001;22:451-457.
40. Dajcs JJ, Thibodeaux BA, Girgis DO, et al. Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit. Invest Ophthalmol Vis Sci. 2002;43:3712-3716.